4G Clinical

4G Clinical’s Senior Director of Strategy Neta Bendelac writes for on the European Medicine Agency’s (EMA) recent recommendations on the management of decentralized clinical trials and the impact this regulation has on clinical trial operations.

“It is critical for sponsors to work closely with regulators to ensure DCTs are conducted safely and in compliance with all regulatory expectations."

Read the full article here: https://bit.ly/3n6gdbz

Recommendations for Navigating New Regulations on Decentralized Clinical Trials - ACRP Regulatory bodies have recently published recommendations that aim to facilitate the conduct of decentralized trails while safeguarding participants and the data collected.

GCSG's US Conference is coming up later this month, and we are excited to be showcasing our clinical supply forecasting tool, 4C Supply® on Tuesday, April 25th. Our very own Casey Ferrier will be highlighting how our tool puts data visibility and scenario planning in the hands of clinical supply professionals, allowing them to have greater control over the production and distribution processes. By providing sponsors with the data they need to make informed decisions, 4C Supply® can help and sponsors streamline their supply chains and reduce costs while ensuring sufficient supplies for patient treatment.

Learn more about the agenda of the event: https://bit.ly/3Ke7AmY